Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Guillet, R.
Right arrow Articles by Kwon, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guillet, R.
Right arrow Articles by Kwon, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Seizure Recurrence and Developmental Disabilities After Neonatal Seizures: Outcomes Are Unrelated to Use of Phenobarbital Prophylaxis

Ronnie Guillet, MD, PhD

Department of Pediatrics, Division of Neonatology, Golisano Children's Hospital

Jennifer Kwon, MD, MPH

Departments of Neurology and Pediatrics, University of Rochester, Rochester, New York, jennifer_kwon{at}urmc.rochester.edu

This study investigated treatment patterns at discharge in infants with neonatal seizures and evaluated the impact of outpatient phenobarbital prophylaxis on the frequency of seizure recurrence and the long-term neurodevelopmental outcome at 1 to 11 years. Infants with neonatal seizures during a 12-year period were identified retrospectively (n = 146), and data were obtained by medical chart review. Outcomes were ascertained by standardized telephone survey. Thirty-three infants (23%) were taking phenobarbital, and 99 infants (68%) were taking no anticonvulsants at discharge. Comparisons were made between these 2 groups. Phenobarbital prophylaxis did not improve neurologic outcomes, either with respect to seizure recurrence or neurologic development. These data have important implications at a time when many are questioning the practice of prophylaxis after neonatal seizures and when newer anticonvulsants are being recommended for treatment of acute neonatal seizures.

Key Words: neonatal seizures • phenobarbital • developmental disabilities

Journal of Child Neurology, Vol. 22, No. 4, 389-395 (2007)
DOI: 10.1177/0883073807301917
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
H. C. Glass and E. Wirrell
Controversies in Neonatal Seizure Management
J Child Neurol, May 1, 2009; 24(5): 591 - 599.
[Abstract] [PDF]

Home page
 PediatricsHome page
R. Guillet and J. M. Kwon
Prophylactic Phenobarbital Administration After Resolution of Neonatal Seizures: Survey of Current Practice
Pediatrics, October 1, 2008; 122(4): 731 - 735.
[Abstract] [Full Text] [PDF]